Treating Non-Squamous NSCLC with High Levels of PD-L1

Treating Non-Squamous NSCLC with High Levels of PD-L1
Don Photo

Don
3 years 113 Views
Category:
Description:
Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope on treating non-squamous, non-small cell lung cancer (NSCLC) patients who express high levels of PD-L1.